NCT06296173

Brief Summary

Perioperative respiratory complications are a major source of morbidity and mortality. Postoperative atelectasis plays a central role in their development. Protective "open lung" mechanical ventilation aims to minimize the occurrence of atelectasis during the perioperative period. Randomized controlled studies have been performed comparing various "open lung" ventilation protocols, but these studies report varying and conflicting effects. The interpretation of these studies is complicated by the absence of imagery supporting the pulmonary impact associated with the use of different ventilation strategies. Imaging studies suggest that the gain in pulmonary gas content in "open lung" ventilation regimens disappears within minutes after the extubation. Thus, the potential benefits of open-lung ventilation appear to be lost if, at the time of extubation, no measures are used to keep the lungs well aerated. Recent expert recommendations on good mechanical ventilation practices in the operating room conclude that there is actually no quality study on extubation. Extubation is a very common practice for anesthesiologists as part of their daily clinical practice. It is therefore imperative to generate evidence on good clinical practice during anesthetic emergence in order to potentially identify an effective extubation strategy to reduce postoperative pulmonary complications.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
270

participants targeted

Target at P75+ for not_applicable

Timeline
11mo left

Started Oct 2024

Typical duration for not_applicable

Geographic Reach
1 country

4 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress64%
Oct 2024Apr 2027

First Submitted

Initial submission to the registry

February 21, 2024

Completed
14 days until next milestone

First Posted

Study publicly available on registry

March 6, 2024

Completed
7 months until next milestone

Study Start

First participant enrolled

October 8, 2024

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2026

Expected
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2027

Last Updated

January 21, 2026

Status Verified

January 1, 2025

Enrollment Period

2.1 years

First QC Date

February 21, 2024

Last Update Submit

January 19, 2026

Conditions

Outcome Measures

Primary Outcomes (3)

  • Average weekly patient recruitment rate

    Achieve a weekly patient recruitment rate of 2 patients per week per center

    Every week. At the end of the study (average 9 months) at the study level.

  • Protocol adherence rate

    Assess adherence to a protocol during emergence from anesthesia, monitoring four criteria (proper positioning (dorsal decubitus or semi-sitting position), correct FiO2 (100% or 50%), appropriate ventilatory mode (manual or pressure support ventilation), and proper end-expiratory pressure (zero or preserved end-expiratory pressure), and noting deviations, with adherence defined as successful performance of all criteria during extubation.

    At the end of surgery for individual assessments. At the end of the study (average 9 months) at the study level.

  • Postoperative pulmonary complications outcome completion rate

    Postoperative pulmonary complications are defined as a composite endpoint that includes atelectasis, pneumonia, acute respiratory distress syndrome, and pulmonary aspiration, according to the StEP-COMPAC definition.

    At postoperative day 7 for individual assessments. At the end of the study (average 9 months) at the study level.

Secondary Outcomes (7)

  • Accuracy of self-reported protocol adherence compared to directly observed protocol adherence

    At the end of the surgery

  • Postoperative pulmonary complications

    At postoperative day 7

  • Amount of supplemental oxygen administered following discharge from the post-anesthesia care unit

    At postoperative day 7 or hospital discharge (earliest of the two)

  • Quality of recovery

    At postoperative day 1

  • Discharge disposition

    At postoperative day 30

  • +2 more secondary outcomes

Other Outcomes (3)

  • Lowest oxygen saturation post-extubation in the operating room

    At operating room exit

  • Time in minutes with oxygen saturation < 85% post-extubation in the operating room

    At operating room exit

  • Re-intubation rate in the operating room and in the post-anesthesia care unit

    At discharge from the post-anesthesia care unit

Study Arms (2)

Open lung extubation

EXPERIMENTAL

At the beginning of emergence, patients will be positioned with the head of the bed elevated to at least 30 degrees and the FiO2 will be set at 50%. At the resumption of spontaneous ventilation or earlier at the discretion of the anesthesiologist, the ventilator will be set to pressure support ventilation mode for the rest of the emergence procedure. The pressure support level will be adjusted to obtain a volume similar to the one used prior to emergence. PEEP will be left unchanged. Anesthesiologists will be instructed not to switch off the ventilator until the patient is extubated.

Other: Protective "open-lung" extubation

Conventional extubation

ACTIVE COMPARATOR

At the beginning of emergence, patients will be positioned in a dorsal decubitus position and the FiO2 will be set at 100%. At the resumption of spontaneous ventilation or earlier at the discretion of the anesthesiologist, the ventilator will be switched off for the rest of the emergence procedure with the adjustable pressure-limiting valve open to atmosphere. Manual ventilation or assistance will be allowed, but the adjustable pressure-limiting valve will be reopened when pausing manual ventilation or assistance.

Other: Conventional extubation

Interventions

Emergence using 100% FiO2, dorsal decubitus position with assistance or manual bag ventilation without PEEP

Conventional extubation

Emergence using 50% FiO2, semi-sitting position with pressure support ventilation and preserved PEEP

Open lung extubation

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adult patients (18 years of age or over)
  • Elective intra-abdominal surgery under general anesthesia.
  • Moderate or high risk of postoperative pulmonary complication according to the ARISCAT score (score of 26 or more)
  • Planned postoperative hospitalization

You may not qualify if:

  • Expected or known difficult intubation according to the treating anesthesiologist
  • Postoperative mechanical ventilation (planned or unplanned)
  • General anesthesia performed outside the main operating room

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (4)

The Ottawa Hospital

Ottawa, Ontario, K1H 8L6, Canada

NOT YET RECRUITING

Unity Health Network

Toronto, Ontario, M5B 1W8, Canada

RECRUITING

Centre Hospitalier de l'Université de Montréal (CHUM)

Montreal, Quebec, H2X 0C1, Canada

RECRUITING

CHU de Québec - Université Laval

Québec, Quebec, G1V 4G2, Canada

RECRUITING

MeSH Terms

Conditions

Lung InjuryVentilator-Induced Lung InjuryPulmonary Atelectasis

Condition Hierarchy (Ancestors)

Lung DiseasesRespiratory Tract DiseasesThoracic InjuriesWounds and Injuries

Study Officials

  • Martin Girard, MD

    Centre hospitalier de l'Université de Montréal (CHUM)

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
Until surgical closure, all will be blinded to treatment allocation. Only specific healthcare professionals (anesthesiologist, respiratory therapist, operating room nurses, unblinded research assistant) will be present during emergence to maintain blinding. Other healthcare team members will remain blinded. Outcome adjudicators, Executive and Steering committee members, and the data analyst will also be blinded. No mechanism for unblinding is planned, as both interventions follow the same diagnostic and treatment algorithms for adverse effects.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: During surgical closure, the definitive ARISCAT score and exclusion criteria will be assessed. Patients will be randomized equally (1:1) using web-based allocation-concealed methods, with stratification by center and ARISCAT risk category. An unblinded research assistant will reveal group allocation to the anesthesiologist and monitor the emergence procedure.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 21, 2024

First Posted

March 6, 2024

Study Start

October 8, 2024

Primary Completion (Estimated)

December 1, 2026

Study Completion (Estimated)

April 1, 2027

Last Updated

January 21, 2026

Record last verified: 2025-01

Data Sharing

IPD Sharing
Will not share

End-of-grant knowledge translation modalities will be used to reach other important stakeholders, researchers and members of the anesthesia community: scientific meetings, open access publication in a Canadian journal, and public presentations with patient partners. Knowledge diffusion on potential difficulties of conducting such trials (and solutions) will be transferred to the research community through meetings of the Canadian Perioperative Anesthesia Clinical Trial group (PACT). A methodological meeting will be organized with participating sites of both pilot and future efficacy phases to enhance protocol applicability before going forward to the efficacy phase. This plan will help recruit more Canadian centres for the efficacy trial and conduct the intervention in these centres.

Locations